Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Thimble Point Acquisition Corp Cl A (THMA)

Thimble Point Acquisition Corp Cl A (THMA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 76,361
  • Shares Outstanding, K 8,211
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade THMA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.01 +3.22%
on 12/02/21
10.10 -7.91%
on 11/29/21
-0.67 (-6.72%)
since 11/03/21
3-Month
9.01 +3.22%
on 12/02/21
10.10 -7.91%
on 11/29/21
-0.60 (-6.06%)
since 09/03/21

Most Recent Stories

More News
Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company

Pear Therapeutics, Inc. (“Pear Therapeutics”), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs) , announced today the completion...

THMA : 9.30 (+1.93%)
Pear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx Conference

Pear Therapeutics, Inc. , the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced management will participate in the Evercore...

THMA : 9.30 (+1.93%)
Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder

Pear Therapeutics, Inc. , the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it has received Breakthrough Device...

THMA : 9.30 (+1.93%)
Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance

Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today provides an update on significant progress...

THMA : 9.30 (+1.93%)
Thimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business Plan

Today, Thimble Point Acquisition Corp, Inc. (NASDAQ: THMA) (“Thimble Point”), a special purpose acquisition company, Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing...

THMA : 9.30 (+1.93%)
Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List

Pear Therapeutics, Inc. today announced the inclusion of Pear’s FDA-authorized prescription digital therapeutics (PDTs) reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update...

THMA : 9.30 (+1.93%)
Pear Therapeutics to Participate in the BTIG Digital Health Forum

Pear Therapeutics, Inc. , the leader in developing and commercializing prescription digital therapeutics (PDTs) to treat serious disease, today announced management’s participation in the virtual BTIG...

THMA : 9.30 (+1.93%)
Pear Therapeutics and Thimble Point Acquisition Corp. Announce Effectiveness of S-4 Registration Statement and Set November 23, 2021 for Thimble Point Special Stockholder Meeting to Vote on Proposed Business Combination

Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing prescription digital therapeutics (“PDTs”) to treat serious disease , and Thimble Point Acquisition Corp. (“Thimble...

THMA : 9.30 (+1.93%)
Pear and Thimble Point Announce Nominees to Board of Directors

Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing prescription digital therapeutics (“PDTs”) to treat serious disease, and Thimble Point Acquisition Corp. (Nasdaq:...

THMA : 9.30 (+1.93%)
INGN : 23.82 (+4.75%)
FB : 196.64 (+0.51%)
Lifshitz Law Firm, P.C. Announces Investigation of CORE, FFWM, PLBN, and THMA

NEW YORK, July 10, 2021 (GLOBE NEWSWIRE) --

CORE : 45.65 (-0.76%)
FFWM : 18.89 (-0.74%)
PLBN : 6.1900 (+0.49%)
THMA : 9.30 (+1.93%)

Business Summary

Thimble Point Acquisition Corp entered into a definitive business combination agreement with Pear Therapeutics.

See More

Key Turning Points

3rd Resistance Point 9.54
2nd Resistance Point 9.43
1st Resistance Point 9.37
Last Price 9.30
1st Support Level 9.19
2nd Support Level 9.08
3rd Support Level 9.02

See More

52-Week High 10.10
Fibonacci 61.8% 9.68
Fibonacci 50% 9.55
Fibonacci 38.2% 9.43
Last Price 9.30
52-Week Low 9.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar